Hi Doole I don't believe it's managements failure to perform rather it all comes down to the almighty dollar. The product works and it will save lives but whoever takes it on will do it at cost or run at a loss. It would need to be a major phama who is able to absorb the costs and off set the loss against other products.. Without the backing of WHO, MMV the acceptance is made 10x harder. I believe the TGA approval will go a long way to these organizatiions adding Artimist to the list of approved treatments.
A short extract from a recent article regarding costs. Patients were not charged for ACTs in Nigeria and Uganda, and rectal artesunate was provided at no cost to the patient in all countries.
SUD Price at posting:
2.3¢ Sentiment: Hold Disclosure: Held
(20min delay)